Hot AI Mandate: US-based VC Invests Globally in Novel Technologies & Platforms Across Life Sciences

26 Jul

Founded in 1986 with offices in the US and Ireland, a venture capital firm recently closed its latest fund, the firm’s largest fund to date with over $1.85B. The firm’s size of investment can largely vary; the firm can invest as little as $50K all the way up to hundreds of millions over the life of investment. The firm is open to investment opportunities globally.

The firm is currently interested in novel concepts and platforms across the life sciences. The firm invests in therapeutics, devices, diagnostics, life science tools, and has a lesser interest in technology-led companies in the healthcare IT space (the firm is not interested in service-based/SaaS healthcare IT businesses). The firm has made many investments in these particular areas: infectious disease, mental health, immunology, genomic and biological tools, data sciences and ways of reimagining diagnostics and therapies. The firm prefers early stage opportunities; in therapeutics, the firm focuses on pre-IND technologies.

The firm only invests in privately held companies that have not previously raised a Series A round or a significant seed round. The firm is a highly hands-on, active investor.

If you are interested in more information about this investor and other investors tracked by LSN, please email resi@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: